Sponsors (4)
The bill shifts NIH animal-research funding and oversight toward U.S. institutions to increase domestic control and transparency, but does so at the cost of reduced international collaboration, higher domestic research costs, and potential capacity strains that could slow scientific progress.
U.S. researchers and institutions (states and territories) gain priority access to NIH animal-research funding, keeping research dollars onshore and increasing domestic grant opportunities.
Hospitals, health systems, and domestic researchers face simpler oversight and compliance because NIH-funded animal research would be concentrated in jurisdictions subject to U.S. animal-welfare and research regulations.
U.S. taxpayers gain transparency about past NIH support for foreign animal research (roughly $2.2 billion in FY2011–FY2021), informing public oversight and potential policy reforms.
U.S. taxpayers and federally funded researchers may face higher overall research costs if animal studies must be relocated domestically, where labor and facility costs are generally higher than abroad.
Scientists, hospitals, and research collaborators internationally will lose or see reduced eligibility for NIH-funded animal research, reducing international collaboration and potentially slowing scientific progress and innovation.
Ongoing multinational studies that rely on overseas animal facilities could be delayed or disrupted, harming research timelines, patient-facing studies, and scientific outcomes.
Based on analysis of 3 sections of legislative text.
Prohibits NIH from funding any research that uses live animals unless the research is conducted within the United States or its territories.
Official title: Amend the Public Health Service Act to prohibit the National Institutes of Health from awarding any support for an activity or program that uses live animals in research unless the research occurs in the United States, and for other purposes.
Introduced May 19, 2025 by Richard Lynn Scott · Last progress May 19, 2025
Bars the National Institutes of Health (NIH) from awarding any federal support for research that uses live animals unless the work is done inside the United States or its territories. It responds to congressional findings that NIH has funded animal research overseas without routine inspections and that such practices risk animal mistreatment. The change amends federal law to restrict NIH funding authority: grants, contracts, cooperative agreements, and technical assistance that involve live animals would be prohibited for foreign institutions, effectively limiting federally supported animal research to domestic locations and U.S. territories.